Sarah Popham joined Atai Life Sciences in 2022 as VP of regulatory affairs. Sarah has over 25 Years of drug development experience and has contributed to many marketed products.
Prior to joining atai Life Sciences, Sarah held multiple regulatory positions at Amgen for 10 Years (UK/US) specifically joining the Company to support the Global expansion strategy. Most recently she served as a Regional Regulatory Head on the executive leadership team where she was responsible for all regulatory activity across 30 + Countries through Canada, Latin America, Middle East, Africa and Turkey.
Prior to Amgen, she held multiple clinical development and regulatory positions at Genentech (US) over an 8 year period, including regulatory filing lead and clinical operations lead roles for key products.
Prior to Genentech, Sarah worked with GSK and Quintiles (UK) for 6 Years.
Sarah holds a Bachelor of Science degree from the University of Bradford, West Yorkshire, UK.